 Christopher Baker
Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tracheostomy | 17 | 2025 | 119 | 6.500 |
Why?
| | Bronchopulmonary Dysplasia | 28 | 2025 | 375 | 6.500 |
Why?
| | Respiration, Artificial | 21 | 2025 | 598 | 5.400 |
Why?
| | Home Care Services | 6 | 2024 | 244 | 2.180 |
Why?
| | Infant, Premature | 18 | 2024 | 535 | 1.950 |
Why?
| | Respiratory Insufficiency | 5 | 2024 | 313 | 1.720 |
Why?
| | Ventilator Weaning | 4 | 2024 | 35 | 1.580 |
Why?
| | Infant, Newborn | 34 | 2025 | 5687 | 1.440 |
Why?
| | Patient Discharge | 7 | 2024 | 853 | 1.240 |
Why?
| | Tracheobronchomalacia | 3 | 2025 | 14 | 1.190 |
Why?
| | Ventilators, Mechanical | 7 | 2023 | 53 | 1.170 |
Why?
| | Infant, Premature, Diseases | 2 | 2021 | 93 | 1.070 |
Why?
| | Infant | 26 | 2025 | 8914 | 1.030 |
Why?
| | Continuity of Patient Care | 3 | 2017 | 275 | 1.010 |
Why?
| | Premature Birth | 5 | 2024 | 310 | 0.980 |
Why?
| | Length of Stay | 2 | 2024 | 1113 | 0.980 |
Why?
| | Fetal Blood | 5 | 2016 | 316 | 0.950 |
Why?
| | Child | 32 | 2024 | 20655 | 0.910 |
Why?
| | Patient Care Team | 4 | 2022 | 605 | 0.880 |
Why?
| | Respiratory Tract Diseases | 2 | 2022 | 150 | 0.850 |
Why?
| | Stem Cells | 3 | 2013 | 578 | 0.820 |
Why?
| | Tracheomalacia | 1 | 2022 | 15 | 0.790 |
Why?
| | Enteral Nutrition | 1 | 2024 | 182 | 0.780 |
Why?
| | Infant, Extremely Premature | 4 | 2022 | 60 | 0.770 |
Why?
| | Tracheoesophageal Fistula | 1 | 2022 | 33 | 0.770 |
Why?
| | Trachea | 1 | 2023 | 221 | 0.750 |
Why?
| | Device Removal | 3 | 2019 | 137 | 0.740 |
Why?
| | Airway Extubation | 2 | 2019 | 54 | 0.730 |
Why?
| | Deglutition Disorders | 1 | 2022 | 131 | 0.700 |
Why?
| | Humans | 63 | 2025 | 128417 | 0.680 |
Why?
| | Feeding and Eating Disorders | 1 | 2022 | 144 | 0.670 |
Why?
| | Lung | 7 | 2024 | 3743 | 0.660 |
Why?
| | Respiratory Tract Fistula | 1 | 2019 | 7 | 0.650 |
Why?
| | Cutaneous Fistula | 1 | 2019 | 13 | 0.650 |
Why?
| | Tracheal Diseases | 1 | 2019 | 16 | 0.640 |
Why?
| | Pediatrics | 4 | 2024 | 1046 | 0.640 |
Why?
| | Hypertension, Pulmonary | 6 | 2024 | 1745 | 0.640 |
Why?
| | Endothelial Cells | 4 | 2013 | 698 | 0.630 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 101 | 0.600 |
Why?
| | Clinical Competence | 2 | 2024 | 1013 | 0.560 |
Why?
| | Curriculum | 3 | 2021 | 917 | 0.550 |
Why?
| | Pulmonary Alveoli | 3 | 2018 | 366 | 0.540 |
Why?
| | Pamphlets | 1 | 2016 | 23 | 0.540 |
Why?
| | Animals, Newborn | 3 | 2015 | 803 | 0.540 |
Why?
| | Internship and Residency | 2 | 2024 | 1048 | 0.530 |
Why?
| | Endothelial Progenitor Cells | 1 | 2016 | 20 | 0.530 |
Why?
| | Airway Obstruction | 2 | 2021 | 149 | 0.520 |
Why?
| | Simulation Training | 1 | 2017 | 82 | 0.510 |
Why?
| | Pulmonary Diffusing Capacity | 1 | 2016 | 74 | 0.510 |
Why?
| | Child, Preschool | 14 | 2024 | 10384 | 0.510 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 117 | 0.510 |
Why?
| | Caregivers | 3 | 2024 | 810 | 0.490 |
Why?
| | Hyperoxia | 3 | 2013 | 87 | 0.470 |
Why?
| | Lung Diseases | 1 | 2021 | 715 | 0.470 |
Why?
| | Neovascularization, Physiologic | 2 | 2013 | 172 | 0.470 |
Why?
| | Clinical Protocols | 1 | 2016 | 252 | 0.470 |
Why?
| | Pre-Eclampsia | 1 | 2016 | 185 | 0.460 |
Why?
| | Human Umbilical Vein Endothelial Cells | 2 | 2022 | 97 | 0.450 |
Why?
| | Central Nervous System Diseases | 1 | 2014 | 67 | 0.440 |
Why?
| | Self Care | 1 | 2016 | 368 | 0.440 |
Why?
| | Organogenesis | 1 | 2014 | 56 | 0.430 |
Why?
| | Neovascularization, Pathologic | 1 | 2015 | 290 | 0.420 |
Why?
| | Anti-Bacterial Agents | 1 | 2023 | 1663 | 0.420 |
Why?
| | Culture Media, Conditioned | 1 | 2013 | 108 | 0.410 |
Why?
| | Bronchitis, Chronic | 1 | 2012 | 19 | 0.400 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2013 | 50 | 0.400 |
Why?
| | Regeneration | 1 | 2014 | 174 | 0.400 |
Why?
| | Umbilical Cord | 1 | 2013 | 84 | 0.400 |
Why?
| | Quality Improvement | 2 | 2017 | 1094 | 0.390 |
Why?
| | Female | 26 | 2025 | 68153 | 0.390 |
Why?
| | Patient Education as Topic | 1 | 2016 | 737 | 0.380 |
Why?
| | Bleomycin | 1 | 2013 | 240 | 0.380 |
Why?
| | Developmental Disabilities | 1 | 2014 | 257 | 0.370 |
Why?
| | Interleukin-8 | 1 | 2012 | 258 | 0.370 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 385 | 0.360 |
Why?
| | Ambulatory Care | 3 | 2024 | 503 | 0.360 |
Why?
| | Sputum | 1 | 2012 | 302 | 0.350 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2013 | 203 | 0.340 |
Why?
| | Communication | 1 | 2016 | 838 | 0.340 |
Why?
| | Male | 21 | 2025 | 62857 | 0.340 |
Why?
| | Hospital Mortality | 1 | 2014 | 844 | 0.340 |
Why?
| | Pulmonary Medicine | 2 | 2024 | 80 | 0.330 |
Why?
| | Acute Lung Injury | 1 | 2013 | 264 | 0.330 |
Why?
| | Positive-Pressure Respiration | 3 | 2023 | 75 | 0.320 |
Why?
| | Algorithms | 1 | 2016 | 1618 | 0.300 |
Why?
| | Argyria | 1 | 2007 | 4 | 0.290 |
Why?
| | Postoperative Complications | 1 | 2019 | 2485 | 0.290 |
Why?
| | Silver | 1 | 2007 | 34 | 0.280 |
Why?
| | Skin Pigmentation | 1 | 2007 | 48 | 0.280 |
Why?
| | Neutrophils | 1 | 2012 | 1193 | 0.270 |
Why?
| | Morbidity | 3 | 2022 | 301 | 0.260 |
Why?
| | Retrospective Studies | 8 | 2025 | 14454 | 0.250 |
Why?
| | Chronic Disease | 3 | 2021 | 1705 | 0.250 |
Why?
| | Pylorus | 1 | 2024 | 17 | 0.220 |
Why?
| | Pregnancy | 5 | 2021 | 6357 | 0.220 |
Why?
| | Adolescent | 6 | 2024 | 20179 | 0.220 |
Why?
| | Cells, Cultured | 4 | 2016 | 4001 | 0.210 |
Why?
| | Colorado | 3 | 2024 | 4375 | 0.200 |
Why?
| | Air Pollution, Indoor | 1 | 2024 | 144 | 0.200 |
Why?
| | Education, Medical, Graduate | 2 | 2024 | 435 | 0.200 |
Why?
| | von Willebrand Diseases | 1 | 2022 | 20 | 0.200 |
Why?
| | Risk Factors | 4 | 2024 | 9704 | 0.190 |
Why?
| | von Willebrand Factor | 1 | 2022 | 63 | 0.190 |
Why?
| | Insufflation | 1 | 2021 | 9 | 0.190 |
Why?
| | Spinal Muscular Atrophies of Childhood | 1 | 2021 | 14 | 0.190 |
Why?
| | Social Determinants of Health | 1 | 2024 | 220 | 0.180 |
Why?
| | Pulmonary Ventilation | 1 | 2021 | 76 | 0.180 |
Why?
| | Flow Cytometry | 2 | 2016 | 1142 | 0.180 |
Why?
| | Steroids | 2 | 2022 | 147 | 0.170 |
Why?
| | Aftercare | 1 | 2021 | 206 | 0.170 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2022 | 221 | 0.160 |
Why?
| | Leukocytes, Mononuclear | 2 | 2013 | 539 | 0.160 |
Why?
| | Emergencies | 1 | 2020 | 155 | 0.160 |
Why?
| | Echocardiography | 2 | 2024 | 623 | 0.160 |
Why?
| | Tracheotomy | 1 | 2019 | 23 | 0.160 |
Why?
| | Influenza Vaccines | 1 | 2024 | 536 | 0.160 |
Why?
| | Polysomnography | 1 | 2019 | 160 | 0.150 |
Why?
| | Glycogen Storage Disease | 1 | 2018 | 19 | 0.150 |
Why?
| | Influenza, Human | 1 | 2024 | 601 | 0.150 |
Why?
| | Dental Cements | 1 | 2017 | 20 | 0.150 |
Why?
| | Cystic Fibrosis | 1 | 2007 | 1057 | 0.140 |
Why?
| | Transitional Care | 1 | 2017 | 37 | 0.140 |
Why?
| | Age Factors | 1 | 2024 | 3103 | 0.140 |
Why?
| | Long-Term Care | 1 | 2017 | 89 | 0.140 |
Why?
| | Cell Proliferation | 3 | 2013 | 2344 | 0.140 |
Why?
| | Young Adult | 3 | 2019 | 12312 | 0.130 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2015 | 141 | 0.130 |
Why?
| | Infant Care | 1 | 2016 | 46 | 0.130 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3020 | 0.130 |
Why?
| | Prospective Studies | 3 | 2024 | 7036 | 0.130 |
Why?
| | Expectorants | 1 | 2016 | 23 | 0.130 |
Why?
| | Interrupted Time Series Analysis | 1 | 2016 | 52 | 0.130 |
Why?
| | Computer Simulation | 1 | 2020 | 939 | 0.130 |
Why?
| | Tidal Volume | 1 | 2016 | 82 | 0.130 |
Why?
| | Rats | 2 | 2015 | 5165 | 0.120 |
Why?
| | Hospitals, Pediatric | 1 | 2019 | 505 | 0.120 |
Why?
| | Adrenal Cortex Hormones | 2 | 2018 | 518 | 0.120 |
Why?
| | Electronic Health Records | 1 | 2022 | 974 | 0.120 |
Why?
| | Diuretics | 1 | 2015 | 74 | 0.120 |
Why?
| | Adrenergic beta-Agonists | 1 | 2015 | 129 | 0.110 |
Why?
| | Monitoring, Physiologic | 1 | 2016 | 266 | 0.110 |
Why?
| | Carbon Dioxide | 1 | 2016 | 260 | 0.110 |
Why?
| | Treatment Outcome | 3 | 2024 | 10151 | 0.100 |
Why?
| | Hernia, Diaphragmatic | 1 | 2013 | 69 | 0.100 |
Why?
| | Immunoenzyme Techniques | 1 | 2013 | 206 | 0.100 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2013 | 120 | 0.100 |
Why?
| | Leukocyte Count | 1 | 2013 | 325 | 0.100 |
Why?
| | United States | 5 | 2022 | 13830 | 0.100 |
Why?
| | Vascular Diseases | 1 | 2015 | 232 | 0.100 |
Why?
| | Lung Diseases, Interstitial | 1 | 2018 | 593 | 0.100 |
Why?
| | Survival Rate | 1 | 2016 | 1869 | 0.090 |
Why?
| | Time Factors | 2 | 2019 | 6482 | 0.090 |
Why?
| | Survival Analysis | 1 | 2014 | 1263 | 0.090 |
Why?
| | Blotting, Western | 1 | 2013 | 1164 | 0.090 |
Why?
| | Maternal Exposure | 1 | 2012 | 175 | 0.090 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 945 | 0.080 |
Why?
| | Risk | 1 | 2012 | 853 | 0.080 |
Why?
| | Outpatients | 2 | 2023 | 366 | 0.080 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4892 | 0.070 |
Why?
| | Risk Assessment | 1 | 2017 | 3232 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2239 | 0.070 |
Why?
| | Animals | 3 | 2015 | 34479 | 0.070 |
Why?
| | Colloids | 1 | 2007 | 57 | 0.070 |
Why?
| | Pulmonary Artery | 1 | 2013 | 1030 | 0.070 |
Why?
| | Surveys and Questionnaires | 3 | 2024 | 5362 | 0.070 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2009 | 500 | 0.070 |
Why?
| | Complementary Therapies | 1 | 2007 | 86 | 0.070 |
Why?
| | Biomarkers | 1 | 2017 | 3880 | 0.070 |
Why?
| | Gestational Age | 2 | 2021 | 867 | 0.070 |
Why?
| | Antioxidants | 1 | 2009 | 538 | 0.060 |
Why?
| | Disease Models, Animal | 1 | 2015 | 3937 | 0.060 |
Why?
| | Respiratory Therapy | 1 | 2024 | 23 | 0.060 |
Why?
| | Nitric Oxide | 1 | 2009 | 882 | 0.060 |
Why?
| | Adult | 2 | 2016 | 35299 | 0.050 |
Why?
| | Tertiary Care Centers | 1 | 2024 | 146 | 0.050 |
Why?
| | Sleep Apnea Syndromes | 1 | 2024 | 79 | 0.050 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2022 | 30 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2024 | 580 | 0.050 |
Why?
| | Weibel-Palade Bodies | 1 | 2022 | 3 | 0.050 |
Why?
| | Child Day Care Centers | 1 | 2022 | 32 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 1 | 2024 | 853 | 0.050 |
Why?
| | Prevalence | 2 | 2021 | 2547 | 0.050 |
Why?
| | Lung Volume Measurements | 1 | 2021 | 43 | 0.050 |
Why?
| | Tomography | 1 | 2021 | 24 | 0.050 |
Why?
| | Tobacco Smoke Pollution | 1 | 2024 | 229 | 0.050 |
Why?
| | Electric Impedance | 1 | 2021 | 101 | 0.050 |
Why?
| | Insurance Coverage | 1 | 2022 | 220 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2022 | 571 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 272 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2024 | 727 | 0.040 |
Why?
| | Mice | 1 | 2015 | 16602 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2021 | 860 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2017 | 183 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1563 | 0.030 |
Why?
| | Societies | 1 | 2016 | 36 | 0.030 |
Why?
| | Vaccination | 1 | 2024 | 1346 | 0.030 |
Why?
| | Parents | 1 | 2024 | 1304 | 0.030 |
Why?
| | Respiration | 1 | 2016 | 190 | 0.030 |
Why?
| | Education, Medical, Continuing | 1 | 2016 | 121 | 0.030 |
Why?
| | Indiana | 1 | 2015 | 33 | 0.030 |
Why?
| | Fundoplication | 1 | 2015 | 54 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1081 | 0.030 |
Why?
| | Infant, Low Birth Weight | 1 | 2015 | 135 | 0.030 |
Why?
| | Gastrostomy | 1 | 2015 | 110 | 0.030 |
Why?
| | Schools, Medical | 1 | 2015 | 131 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2024 | 5039 | 0.030 |
Why?
| | Administration, Inhalation | 1 | 2015 | 661 | 0.030 |
Why?
| | Software | 1 | 2017 | 608 | 0.020 |
Why?
| | Heart Defects, Congenital | 1 | 2018 | 740 | 0.020 |
Why?
| | Ultrasonography | 1 | 2015 | 710 | 0.020 |
Why?
| | Disease Management | 1 | 2015 | 587 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2017 | 1336 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3044 | 0.020 |
Why?
| | Colony-Forming Units Assay | 1 | 2009 | 90 | 0.020 |
Why?
| | Logistic Models | 1 | 2015 | 1974 | 0.020 |
Why?
| | Air | 1 | 2009 | 36 | 0.020 |
Why?
| | Cell Shape | 1 | 2009 | 55 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 81 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2009 | 197 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2523 | 0.020 |
Why?
| | Incidence | 1 | 2015 | 2616 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2015 | 2721 | 0.020 |
Why?
| | Signal Transduction | 1 | 2009 | 4826 | 0.010 |
Why?
|
|
Baker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|